WALTHAM, Mass.--(BUSINESS WIRE)--The population of hospitalized patients with diabetes is on the rise, as is the cost and intensity of their care. Glytec is partnering with the American Hospital Association to deliver a webinar that brings greater attention and awareness to reducing risks and improving safety for patients with diabetes.
The webinar will focus specifically on hypoglycemia, a state of abnormally low blood sugar that can lead to significant complications, including death, and carries substantive financial implications for patients and providers alike. The Centers for Medicare & Medicaid Services (CMS) identifies hypoglycemia as the third most common adverse drug event among hospitalized patients, which is why a hypoglycemia quality measure is currently under development. Are you prepared? Attend the webinar to learn more.
You may register for the webinar here.
Improving the Quality and Cost of Diabetes Care
How Florida Hospital System Discovered and Reduced Hypoglycemia Risks
December 13, 2018
1-2 pm Eastern
12-1 pm Central
10-11 am Pacific
Dr. Richard E. Pratley of Florida Hospital System
Dr. Steven V. Edelman of UC San Diego Health
Hypoglycemia in the hospital is costly, extremely serious and largely preventable -- and insulin is the #1 precipitating variable. Given one of every three hospitalized patients requires insulin therapy during their stay, mainly those with diabetes, the population susceptible to hypoglycemia is considerable. This webinar will examine how Florida Hospital System discovered that patients who experienced hypoglycemia had substantially higher mortality rates, lengths of stay and readmission rates than patients with normal glycemia, which added more than $45 million a year to the cost of care. This webinar will also showcase the series of strategic initiatives and technology investments that led Florida Hospital System to achieve marked improvements in outcomes.
• The clinical and financial implications of hypoglycemia
• Uncovering hypoglycemia risks through data analysis
• What comprises the proposed CMS hypoglycemia quality measure and how you should prepare
• Steps you can take to elevate insulin safety, hypoglycemia prevention and glycemic management as strategic priorities for your hospital
Glytec is the pioneer of personalized digital therapeutics, enabling best practices for insulin optimization across the continuum of care. The company’s patented and FDA-cleared software-as-a-medical-device solutions improve the safety and health of people with diabetes in the hospital and at home. Glytec combines evidence-based decision support technologies with expert clinical services to make insulin a more effective medication option for the millions unable to achieve their treatment goals, leading to reductions in A1C, hypoglycemia and other complications as well as avoidable ED visits, hospitalizations, readmissions and drug waste. The company has offices in Waltham, Massachusetts and Greenville, South Carolina. For more information visit www.glytecsystems.com.